Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) — Market Cap & Net Worth

$326.32 Million USD · CN¥2.23 Billion CNY · Rank #14528

Market Cap & Net Worth: Shanxi C&Y Pharmaceutical Group Co Ltd (300254)

Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) has a market capitalization of $326.32 Million (CN¥2.23 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #14528 globally and #4347 in its home market, demonstrating a -1.03% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanxi C&Y Pharmaceutical Group Co Ltd's stock price CN¥8.67 by its total outstanding shares 257208563 (257.21 Million). Also see Shanxi C&Y Pharmaceutical Group Co Ltd balance sheet assets for a full breakdown of the balance sheet.

Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap History: 2015 to 2026

Shanxi C&Y Pharmaceutical Group Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.09 Billion to $326.32 Million (-9.26% CAGR). Also see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) cash flow conversion for how efficiently the company converts equity into cash flow.

Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 300254 stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.44x

Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 0.44 times its annual revenue

Industry average: 0.57x Lower than industry average

Latest Price to Earnings (P/E) Ratio

15.33x

Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 15.33 times its annual earnings

Industry average: 2.01x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$717.38 Million	$746.08 Million	$30.15 Million	0.96x	23.80x
2017	$384.82 Million	$938.93 Million	$21.67 Million	0.41x	17.76x
2018	$243.26 Million	$1.14 Billion	$7.24 Million	0.21x	33.59x
2019	$305.24 Million	$1.13 Billion	$5.30 Million	0.27x	57.63x
2020	$259.32 Million	$848.07 Million	-$262.37 Million	0.31x	N/A
2021	$327.07 Million	$930.37 Million	-$91.44 Million	0.35x	N/A
2022	$254.81 Million	$829.00 Million	-$118.52 Million	0.31x	N/A
2023	$362.45 Million	$799.31 Million	$25.20 Million	0.45x	14.39x
2024	$329.33 Million	$846.61 Million	$42.19 Million	0.39x	7.81x
2025	$380.89 Million	$870.79 Million	$24.85 Million	0.44x	15.33x

Competitor Companies of 300254 by Market Capitalization

Companies near Shanxi C&Y Pharmaceutical Group Co Ltd in the global market cap rankings as of September 19, 2026. Review Shanxi C&Y Pharmaceutical Group Co Ltd (300254) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Shanxi C&Y Pharmaceutical Group Co Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#518	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#613	GALDERMA GROUP AG	NYSE:GALDY	$44.92 Billion	$38.53
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.90
#670	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$40.99 Billion	CN¥43.91

Shanxi C&Y Pharmaceutical Group Co Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Shanxi C&Y Pharmaceutical Group Co Ltd's market cap moved from $1.09 Billion to $ 326.32 Million, with a yearly change of -9.26%.

Year	Market Cap	Change (%)
2026	CN¥326.32 Million	-14.33%
2025	CN¥380.89 Million	+15.66%
2024	CN¥329.33 Million	-9.14%
2023	CN¥362.45 Million	+42.25%
2022	CN¥254.81 Million	-22.09%
2021	CN¥327.07 Million	+26.12%
2020	CN¥259.32 Million	-15.04%
2019	CN¥305.24 Million	+25.48%
2018	CN¥243.26 Million	-36.79%
2017	CN¥384.82 Million	-46.36%
2016	CN¥717.38 Million	-34.12%
2015	CN¥1.09 Billion	--

End of Day Market Cap According to Different Sources

On Sep 19th, 2026 the market cap of Shanxi C&Y Pharmaceutical Group Co Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$326.32 Million USD
MoneyControl	$326.32 Million USD
MarketWatch	$326.32 Million USD
marketcap.company	$326.32 Million USD
Reuters	$326.32 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$326.32 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14528 Global

#4347 in China

Share Price

CN¥8.67

Change (1 day)

+0.46%

52-Week Range

CN¥7.27 - CN¥14.68

All Time High

CN¥31.09